AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$1.58B |
| 2 |
McKesson
MCK
|
+$961M |
| 3 |
Applied Materials
AMAT
|
+$903M |
| 4 |
Microsoft
MSFT
|
+$749M |
| 5 |
Progressive
PGR
|
+$743M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$1.13B |
| 2 |
Arista Networks
ANET
|
+$1.09B |
| 3 |
Costco
COST
|
+$1.03B |
| 4 |
Tractor Supply
TSCO
|
+$550M |
| 5 |
Amazon
AMZN
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.3% |
| 2 | Financials | 11.88% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.56% |
| 5 | Communication Services | 10.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
2576
DELISTED
Apellis Pharmaceuticals
APLS
| $553K | ﹤0.01% |
31,929
-12,983
| -29% | -$240K |
|
2577
Vir Biotechnology
VIR
$1.48B
| $552K | ﹤0.01% |
109,620
| – | – |
|
2578
iShares US Real Estate ETF
IYR
$4.74B
| $552K | ﹤0.01% |
5,829
-555
| -9% | -$51.8K |
|
|
ARIS
2579
DELISTED
Aris Water Solutions
ARIS
| $552K | ﹤0.01% |
23,330
| – | – |
|
2580
EyePoint Inc
EYPT
$1.03B
| $551K | ﹤0.01% |
58,590
+7,700
| +15% | +$53.2K |
|
2581
Orthofix Medical
OFIX
$474M
| $551K | ﹤0.01% |
49,409
-48,470
| -50% | -$601K |
|
2582
Frontier Group Holdings
ULCC
$1.36B
| $550K | ﹤0.01% |
151,390
+117,410
| +346% | +$430K |
|
2583
Organogenesis Holdings
ORGO
$324M
| $549K | ﹤0.01% |
149,890
+13,860
| +10% | +$51.7K |
|
|
DHIL
2584
DELISTED
Diamond Hill
DHIL
| $548K | ﹤0.01% |
3,773
+1,800
| +91% | +$248K |
|
|
SAGE
2585
DELISTED
Sage Therapeutics
SAGE
| $546K | ﹤0.01% |
59,900
| – | – |
|
|
NMAX
2586
Newsmax Inc
NMAX
$1.01B
| $545K | ﹤0.01% |
+36,000
| New | +$943K |
|
|
PKST
2587
DELISTED
Peakstone Realty Trust
PKST
| $544K | ﹤0.01% |
41,190
+1,400
| +4% | +$17.2K |
|
2588
Preformed Line Products
PLPC
$1.49B
| $543K | ﹤0.01% |
3,400
+1,400
| +70% | +$199K |
|
2589
Tango Therapeutics
TNGX
$4.36B
| $543K | ﹤0.01% |
106,010
+41,070
| +63% | +$102K |
|
|
FFWM
2590
DELISTED
First Foundation Inc
FFWM
| $543K | ﹤0.01% |
106,390
-135,152
| -56% | -$692K |
|
2591
Arvinas
ARVN
$533M
| $543K | ﹤0.01% |
73,720
| – | – |
|
2592
Ennis
EBF
$550M
| $542K | ﹤0.01% |
29,906
-1,530
| -5% | -$28.7K |
|
2593
Spyre Therapeutics
SYRE
$8.65B
| $542K | ﹤0.01% |
36,230
| – | – |
|
|
EHAB
2594
DELISTED
Enhabit
EHAB
| $541K | ﹤0.01% |
56,090
-400
| -0.7% | -$3.69K |
|
2595
Intrepid Potash
IPI
$456M
| $541K | ﹤0.01% |
15,130
+2,930
| +24% | +$99.9K |
|
|
SMLR
2596
DELISTED
Semler Scientific
SMLR
| $540K | ﹤0.01% |
+13,930
| New | +$497K |
|
|
GB
2597
DELISTED
Global Blue Group Holding
GB
| $538K | ﹤0.01% |
+72,036
| New | +$534K |
|
2598
OptimizeRx
OPRX
$120M
| $538K | ﹤0.01% |
39,850
+12,800
| +47% | +$140K |
|
2599
Zegna
ZGN
$3.91B
| $538K | ﹤0.01% |
+62,900
| New | +$507K |
|
2600
Capital City Bank Group
CCBG
$892M
| $537K | ﹤0.01% |
13,654
| – | – |
|
Similar funds
AllianceBernstein's Q2 2025 Portfolio in Review
As of Q2 2025, AllianceBernstein held 3,383 positions worth $307B, up 11% from $276B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
AllianceBernstein's Q2 2025 filing shows 182 new, 1,436 increased, 1,245 reduced and 150 closed positions. Its largest new stake was Star Bulk Carriers: 3,765,155 shares worth $64.9M. The largest sale was Zoetis, an estimated $1.13B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q2 2025 buy was Star Bulk Carriers: 3,765,155 shares worth $64.9M.
- AllianceBernstein added most to Stryker in Q2 2025, an estimated $1.58B increase.
- AllianceBernstein's biggest Q2 2025 reduction was Zoetis, cutting an estimated $1.13B.
- AllianceBernstein fully exited Discover Financial Services in Q2 2025, selling an estimated $123M.
- AllianceBernstein's ten largest holdings make up 32% of its $307B portfolio in Q2 2025.
- AllianceBernstein opened 182 new positions and closed 150 in Q2 2025.
- AllianceBernstein's portfolio value rose 11% quarter-over-quarter to $307B.
Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.